Indoco Remedies's new solid dosages facility at Baddi receives UK-MHRA approval

Capital Market
Last Updated at May 8, 2019 12:05 IST

On 08 May 2019

Indoco Remedies announced that it received approval from the UKMHRA (Medicines and Healthcare Products Regulatory Agency) for its new solid dosages manufacturing facility in Baddi, Himachal Pradesh (Baddi III unit). The inspection was held from 16th to 18th October, 2018. Thefacility is spread over an area of 18000 sq m, with manufacturing capacity of 4.3 billion tablets and 50 million capsules p.a

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)